Privia Health Group, Inc. — Form 8-K Summary
Business Context and Reporting Period
Privia Health Group, Inc. filed a Form 8-K dated August 27, 2021, reporting amendments to its secured credit facilities. The company is an emerging growth company; its common stock trades on Nasdaq under the symbol PRVA.
Material Financing Changes
- The company became the parent guarantor under the amended credit agreement and granted Silicon Valley Bank a first-priority security interest in substantially all of its real and personal property, subject to permitted liens.
- The revolving loan facility increased from $15.0 million to $65.0 million.
- The letter-of-credit sub-facility increased from $2.0 million to $5.0 million.
- The maturity date for the credit facilities was extended to August 27, 2026.
- The term loan facility remains authorized at $35.0 million. As of June 30, 2021, $33.7 million of term loan principal was outstanding.
Interest, Amortization, and Covenants
- Eurodollar borrowings bear interest at LIBOR plus an applicable margin, subject to a 0.5% floor. ABR borrowings bear interest at the applicable ABR rate plus a margin, subject to a 1.5% floor. The filing text does not provide the applicable margins.
- Required term loan amortization is 0.625% of original principal per fiscal quarter from the quarter ending September 30, 2021 through the quarter ending June 30, 2024, increasing to 1.25% per quarter thereafter.
- A 1.0% prepayment premium applies to term loans prepaid within six months after the amendment’s effective date.
- Financial covenants are springing and apply when company cash is below 125% of outstanding credit-facility borrowings or when at least $15.0 million is outstanding under the revolving facility.
- When triggered, the company must maintain a fixed-charge coverage ratio of at least 1.20 to 1.0 and a maximum leverage ratio of 3.5 to 1.0 for the quarters ending September 30 and December 31, 2021, declining to 3.0 to 1.0 thereafter.
Other Financial Metrics and Outlook
This filing does not provide revenue, profit, cash flow, operating margin, liquidity balances, management guidance, or a broader business outlook. The principal unusual item is the material expansion and extension of the company’s secured borrowing capacity, together with expanded collateral and parent-guarantee obligations.
Important Facts for Investors to Verify
- Actual revolver borrowings, undrawn availability, letters of credit, and cash balances after the amendment.
- The applicable interest-rate margins and the impact of any LIBOR replacement provisions.
- Compliance with the springing fixed-charge coverage and leverage covenants.
- The company’s collateral obligations and the scope of permitted liens.
- Term loan amortization, prepayment activity, and debt maturities through August 27, 2026.